Savior LLC’s Tectonic Therapeutic TECX Stock Holding History

Savior LLC’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21	Closed	-$1K	–	224
2021 Q3	$1K	Sell	21 -58	-73%	-$4.76K	﹤0.01%	190
2021 Q2	$8K	Hold	79	–	–	0.01%	468
2021 Q1	$12K	Buy	+79	New	+$12.8K	0.01%	377

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Savior LLC's TECX Position: Q4 2021 in Review

Savior LLC sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 21 shares — an estimated $1K sold.

Savior LLC first reported a position in TECX in Q1 2021 and held it in 3 quarters. The position peaked at $12K in Q1 2021. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

Savior LLC reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
Savior LLC sold 21 Tectonic Therapeutic shares in Q4 2021, an estimated $1K.
Savior LLC first reported a position in Tectonic Therapeutic in Q1 2021 and held it in 3 quarters.
Savior LLC's Tectonic Therapeutic position peaked at $12K in Q1 2021.
92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Savior LLC's 13F filing for Q4 2021, filed 3 Feb 2022.